Opioids Market Report 2026

Opioids Market Overview

• Opioids market size has reached to $23.98 billion in 2025 • Expected to grow to $28.59 billion in 2030 at a compound annual growth rate (CAGR) of 3.8% • Growth Driver: Increasing Prevalence Of Chronic Diseases To Drive The Growth Of Opioids Market • Market Trend: Innovative Drug Solutions Transforming The Opioid Market Landscape • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Opioids Market?

Opioids refer to a group of powerful medications extracted or manufactured from the opium poppy plant that works on the neurological system to alleviate the effects of pain. They are extremely useful in the treatment of moderate to severe pain, such as post-surgery pain, cancer-related pain, or chronic pain disorders, as well as coughing and diarrhea. The main types of opioid products are methadone, codeine, fentanyl, oxycodone, morphine, hydrocodone and others. Methadone is an opioid enslavement treatment pharmaceutical, that's utilized in medication-assisted treatment (Tangle) programs to help individuals in lessening or ceasing their utilization of heroin or other opioids. They work through various receptor bindings, such as strong agonists and mild to moderate agonists. They are administered for various symptoms or indications, such as inflammatory conditions, musculoskeletal pain, neuropathic pain and cancer pain and are available in hospitals, retail pharmacies and online pharmacies. They are used in various applications, such as pain management, cough treatment and diarrhea treatment.

What Is The Opioids Market Growth Forecast?

The opioids market size is expected to see steady growth in the next few years. It will grow to $28.59 billion in 2030 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to growth in chronic pain population, development of safer opioid formulations, expansion of palliative care services, increasing regulatory clarity for controlled substances, rising demand for effective pain management in aging populations. Major trends in the forecast period include precision-guided opioid therapy development, digital prescription monitoring integration, shift toward abuse-deterrent formulations, expansion of long-acting and extended-release opioids, growing use of opioids in oncology pain management.

Global Opioids Market Segmentation

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types 2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist 3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain 4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies 5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment Subsegments: 1) By Methadone: Methadone Tablets, Methadone Oral Solution 2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations 3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets 4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations 5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules 6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations 7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

What Is The Driver Of The Opioids Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the opioids market going forward. Chronic diseases, also known as non-communicable diseases (NCDs), refer to long-term medical conditions that typically progress slowly and persist over an extended period. These conditions often last for years or even a lifetime and generally do not resolve on their own. The increasing prevalence of chronic diseases is a major factor in the opioids market. As more people develop chronic diseases and experience chronic pain, there is an increased demand for opioids. Opioid use in chronic disease management is a complex and evolving area of medicine, and it effectively relieves pain. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the opioids industry.

Key Players In The Global Opioids Market

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Global Opioids Market Trends and Insights

Major companies operating in the opioid market are focused on innovating advanced drug solutions to intensify their position. The discovery of new medications can treat diseases and improve healthcare and scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a US-based provider of solutions for treating opioid addiction, stated that the US Food and Drug Administration authorized Brixadi (buprenorphine) extended-release injectable for subcutaneous utilize (beneath the skin) for the treatment of direct to extreme opioid utilize clutter (OUD). It is the primary and sole week-after-week and month-to-month subcutaneous infusion for direct to serious OUD and the primary buprenorphine injectable using FluidCrystal Injection Depot Technology. Patients who receive oral buprenorphine-containing medications can be transitioned to equal dosages if the prescription advice is followed.

What Are Latest Mergers And Acquisitions In The Opioids Market?

In March 2023, Indivior PLC, a US-based specialty medicines company, acquired Opiant Pharmaceuticals Inc. for $145 million. This acquisition of Opiant gives Indivior a complete and relevant treatment platform to address the ongoing opioid and overdose problem in the United States. It also strengthens Indivior's addiction treatment and science portfolio by acquiring Opiant's late-stage assets, particularly OPNT003. Opiant Pharmaceuticals Inc. is a US-based developer of therapies for opioid drug overdose and addiction.

Regional Insights

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Opioids Market?

The opioids market consists of sales of oxycodone (OxyContin), hydrocodone (Vicodin), morphine and methadone. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Opioids Market Report 2026?

The opioids market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the opioids industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.